Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.81 Analyst target: $40.80 Upside: 2154.14%
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company is headquartered in The Woodlands, Texas.
See the full interactive analysis & chart →Informational only — not investment advice.